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The first two cases in France of botulism due to 
Clostridium baratii type F were identified in November 
2014, in the same family. Both cases required pro-
longed respiratory assistance. One of the cases had 
extremely high toxin serum levels and remained 
paralysed for two weeks. Investigations strongly 
supported the hypothesis of a common exposure 
during a family meal with high level contamination 
of the source. However, all analyses of leftover food 
remained negative.
On 12 November 2014, two cases of botulism were 
notified to the regional health agency (ARS) in France. 
The cases were two women in the same family. They 
were hospitalised in intensive care where they received 
respiratory assistance and could therefore not be inter-
viewed. Epidemiological and microbiological investi-
gations were conducted by the regional office of the 
French Institute of Public Health Surveillance (InVS) 
and the national reference centre (NRC) for botulism 
in order to confirm the outbreak and to determine the 
source of exposure.
Case descriptions
Case 1 was a woman in her 60s with symptom onset 
on 10 November 2014 around 8 pm (20 h after the fam-
ily meal) including hypercapnia, gradually descend-
ing flaccid paralysis, complete respiratory muscular 
paralysis and bilateral non-reactive mydriasis. She 
was immediately admitted to intensive care requiring 
mechanical ventilation. Case 1 remained completely 
paralysed (limbs, ocular and respiratory muscles) for 
two weeks. She needed respiratory assistance for 46 
days. On 6 January 2015, she was discharged from 
hospital with a persisting flaccid paraparesis of lower 
limbs.
Case 2 was a woman in her late 20s with symptom 
onset on 11 November 2014 around 8 pm (44 h after 
the meal), gradually developing diplopia, ptosis, dys-
phonia, dysphagia and respiratory distress. She was 
admitted to intensive care on 12 November with flac-
cid paraparesis and respiratory paralysis. She needed 
respiratory assistance for 11 days. On 1 December she 
had fully recovered and was discharged from hospital.
No predisposing factors for intestinal and wound botu-
lism such as antibiotic treatment or gastrointestinal ill-
ness during the preceding weeks or a skin lesion were 
identified for either case.
On 13 November, and before identification of the type 
of neurotoxin, both cases received intravenous botu-
linum antitoxin type ABE, which was inadequate for 
treatment of botulinum neurotoxin type F (BoNT/F) [1].
Epidemiological investigation
Both women had participated in a meal together 
with six other family members on 9 November 2014. 
Telephone interviews with family members were con-
ducted to identify epidemiological links between the 
cases. The two patients also had had lunch together 
on 6 November in a cafeteria but eaten different meals. 
They live in different towns and had not met on any 
other occasion during the two weeks before symptom 
onset.
The only common exposure consistent with the usual 
incubation period of botulism (12–36 h [2]) was the 
family meal at the home of a family member. The food 
list included industrially processed food (potato chips, 
drinks, pre-packaged grated carrots and raw beets, 
country pâté and cheese) except for two artisanal fruit 
tarts, raw tomatoes, roast beef and pork and home-
made mayonnaise. Beef and pork roasts were cooked 
by Case 1 without additional ingredients. The two cases 
had shared the same bottle of alcopop (a flavoured 
alcoholic beverage with an alcohol concentration of 
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5%), the only common exposure not shared with any 
other person. One person drank another bottle of the 
same type. The patients had no other common con-
sumption. No food classically at risk of botulism such 
as home-made cured meat products or canned food 
was identified.
Laboratory investigation
The NRC confirmed the diagnosis of botulism on 17 
November with an extremely high BoNT/F serum level 
for Case 1 (ca 400 mouse lethal doses (MLD)/mL) and 
a lower level for Case 2 (1–2 MLD/mL). BoNT/F was 
identified in a stool sample of Case 1 (160 MLD/g), 
whereas no toxin was detected at the limit of detection 
(20 MLD/g) for Case 2. Clostridium baratii was isolated 
from stool samples of both patients.
Several food leftovers (pâté, roast beef, mayonnaise 
and apple tart) were analysed by the NRC. Two empty 
and one full alcopop bottles were tested. All food and 
drink samples tested negative for toxin (mouse bioas-
say) and for the presence of neurotoxigenic Clostridium 
(PCR and culture).
Discussion
Investigations confirmed two cases of botulism type 
F due to C. baratii. The very high BoNT/F level in the 
serum of Case 1 suggests a high level of toxin con-
tamination of the source, yet the analyses of the food 
items remained negative. However, the family meal 
was the only plausible common exposure. Repeated 
interviews of the family and of Case 2, after recovery, 
were not conclusive. As the only item exclusively con-
sumed by the cases, the shared alcopop bottle was 
highly suspected. However, all microbiological analy-
ses were negative. Furthermore, the acidity of the 
drink (pH = 3.5) was not compatible with C. botulinum 
growth and toxin production [3].
Not all food items eaten during the meal of 9 November 
could be tested, but the ones consumed by the two 
patients, with the exception of potato chips and roast 
pork that were fully consumed, were all tested and 
were negative.
Other possible routes of C. baratii infection include 
skin lesions or intestinal colonisation [1,2,4]. Neither 
skin lesions nor intestinal disorders nor predisposing 
gastrointestinal factors were identified in either case, 
making those routes of infection improbable.
Active case search has been carried out by interview-
ing family members and through the mandatory botu-
lism notification system. No other case was identified 
locally or elsewhere in France.
Botulism type F is extremely unusual in France (no 
case reported up to now) and across the world. The 
few documented cases of botulism type F were mostly 
reported in the United States (US) [1,4-11]. Between 
1981 and 2002, 13 cases of adult botulism type F were 
notified to the US surveillance system. All cases were 
sporadic; no clustering was described [4].
Characteristic early symptoms of foodborne botulism 
type A, B and E are blurred vision, dysphagia, dyspho-
nia, marked fatigue and vertigo. Neurological symp-
toms are always descending the body [2]. Botulism 
type F, due to C. botulinum or C. baratii, commonly 
causes severe illness with tetraplegia and respiratory 
distress [4,6-10,12] often preceding the neurological 
symptoms. The presentation of Case 1 with rapidly pro-
gressing severe respiratory distress as first symptom 
was consistent with the case series described in the 
US, where mean duration of respiratory support was 
reported to be 24 days (10–84 days) and duration of 
neuromuscular impairment eight days [4].
BoNT/F is usually detected in serum and gastric liq-
uid but irregularly found in stool samples. C. botuli-
num F and C. baratii F are usually isolated from stools 
[6,7,9,12-14]. Here, BoNT/F was detected in serum 
and in stool samples. The bacteria were isolated from 
stools.
Food items most often associated with botulism type 
F are canned tuna or home-made meat preparations 
(dried, canned or fresh) such as liver pâté, dried meat 
or raw-dried game [5,7,15,16]. However, for most cases 
documented in the literature, the source of contamina-
tion is not reported [1,4,13,14]. For the present cluster, 
the food items consumed at the suspected meal were 
not ones typically incriminated for botulism. Indeed, 
most food items eaten by the cases were industrial 
products. It is thus important to widen the scope of the 
investigation into food items but also other possible 
sources of contamination. Continuous mandatory noti-
fication of botulism cases will help identify other toxin 
F cases and direct future investigations.
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